Investigating Regulatory RNAs in Cardiometabolic Disease

The Sallam lab is in the Department of Medicine in the David Geffen School of Medicine at UCLA. Located in the state-of-the-art Cardiovascular Theme Facility in the CHS building. Our lab uses cellular, molecular, and disease models to determine how genes impact cardiovascular disease.

In the News

• July 19, 2021: UCLA Newsroom
  RNA modification may protect against liver disease, explain liver fat differences between sexes
• February 12, 2018: Nature Medicine
  Newly discovered gene may protect against heart disease; Transcriptional regulation of macrophage cholesterol efflux and atherogenesis by along noncoding RNA.
• August 28, 2017: UCLA Newsroom
  Gene therapy using ‘junk DNA’ could lower risk for heart disease